Best Biotech Stocks to Buy Now (2022)Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS INC | $5.98B | $471.57M | $305.20M | $434.92M | $3.08 | 42.35% | 28.66% | 156.67% | N/A | ||
| EXEL | EXELIXIS INC | $6.75B | $1.52B | $401.79M | $298.04M | $0.94 | 47.52% | 42.71% | 327.27% | 99.16% | ||
| INCY | INCYTE CORP | $16.40B | $3.32B | $694.45M | $945.01M | $4.27 | 22.05% | 20.51% | 177.27% | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.09B | $153.72M | $60.73M | $45.06M | $0.44 | 27.95% | N/A | -36.23% | N/A | ||
| UTHR | UNITED THERAPEUTICS CORP | $9.98B | $1.79B | $874.60M | $630.80M | $13.97 | 12.45% | 1.85% | 32.29% | 8.76% | ||
| MRNA | MODERNA INC | $66.95B | $23.00B | $15.97B | $14.06B | $34.97 | 227.61% | N/A | 302.42% | N/A | ||
| XOMA | XOMA CORP | $220.66M | $40.98M | $18.72M | $9.54M | $0.86 | 39.30% | 27.19% | 43.33% | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $3.00B | $364.29M | $104.97M | $58.11M | $0.98 | 54.76% | N/A | -48.69% | N/A | ||
| SESN | SESEN BIO INC | $140.82M | $20.00M | $35.40M | $47.80M | $0.25 | 12.49% | -7.73% | N/A | 2.59% | ||
| CORT | CORCEPT THERAPEUTICS INC | $3.01B | $392.03M | $134.12M | $112.72M | $1.02 | 14.26% | 29.25% | 21.43% | 37.18% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $76.64B | $8.35B | $4.13B | $3.19B | $12.47 | 24.94% | 31.40% | 62.37% | 64.03% | ||
| GMAB | GENMAB A | $23.09B | $1.27B | $582.54M | $334.79M | $0.51 | -22.62% | N/A | -60.71% | N/A | ||
| AVIR | ATEA PHARMACEUTICALS INC | $706.03M | $224.99M | $25.91M | $15.53M | $0.18 | 28.56% | N/A | -85.83% | N/A | ||
| LJPC | LA JOLLA PHARMACEUTICAL CO | $158.45M | $52.01M | $17.40M | $5.24M | $0.20 | -13.27% | 167.18% | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $67.82B | $14.23B | $6.70B | $5.69B | $53.37 | 14.88% | 22.13% | -9.37% | 37.25% | ||
| VNDA | VANDA PHARMACEUTICALS INC | $580.89M | $262.70M | $18.36M | $10.99M | $0.21 | 1.61% | 10.96% | -64.41% | N/A | ||
| CDMO | AVID BIOSERVICES INC | $1.09B | $119.60M | $19.82M | $127.67M | $2.08 | 24.75% | 15.72% | 3,366.67% | N/A | 2022-09-06 | |
| SIGA | SIGA TECHNOLOGIES INC | $1.66B | $147.41M | $92.53M | $71.77M | $0.96 | 54.42% | 47.26% | 71.43% | N/A | ||
| TECH | BIO-TECHNE CORP | $14.17B | $1.08B | $352.93M | $225.49M | $5.75 | 26.96% | 14.74% | 20.04% | 23.64% | ||
| GNFT | GENFIT SA | $242.10M | $93.02M | $86.24M | $73.11M | $1.64 | 927.89% | N/A | N/A | N/A | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.15B | $87.89M | -$152.92M | -$156.72M | -$1.16 | 52.60% | 191.16% | N/A | N/A | ||
| CLSD | CLEARSIDE BIOMEDICAL INC | $96.84M | $29.89M | $262.00k | $83.00k | $0.01 | 680.16% | 356.96% | N/A | N/A | ||
| IMTX | IMMATICS NV | $782.19M | $138.58M | $24.66M | $16.10M | $0.27 | 284.86% | N/A | N/A | N/A | ||
| BNTX | BIONTECH SE | $38.21B | $21.62B | $17.28B | $11.99B | $78.89 | 141.15% | N/A | 348.54% | N/A | ||
| ATNM | ACTINIUM PHARMACEUTICALS INC | $128.67M | $1.46M | -$24.05M | -$24.58M | -$1.14 | 135.05% | N/A | N/A | N/A | ||
| UPC | UNIVERSE PHARMACEUTICALS INC | $14.36M | $47.98M | $14.23M | $11.32M | $0.70 | 56.27% | N/A | 48.94% | N/A | ||
| SLGL | SOL-GEL TECHNOLOGIES LTD | $145.07M | $33.16M | $10.32M | $9.59M | $0.42 | 471.60% | N/A | N/A | N/A | ||
| ALEC | ALECTOR INC | $1.05B | $300.73M | $46.62M | $36.26M | $0.45 | 1,303.00% | N/A | N/A | N/A | ||
| LPCN | LIPOCINE INC | $64.17M | $16.64M | $3.53M | $3.42M | $0.04 | N/A | N/A | N/A | N/A | ||
| CLNN | CLENE INC | $215.07M | $540.00k | $18.51M | $16.66M | $0.28 | 54.73% | N/A | N/A | N/A | ||
| DVAX | DYNAVAX TECHNOLOGIES CORP | $2.15B | $673.80M | $248.32M | $228.39M | $1.86 | 298.54% | 144.53% | N/A | N/A | ||
| CARA | CARA THERAPEUTICS INC | $634.50M | $48.89M | -$64.74M | -$66.35M | -$1.26 | -60.35% | 121.79% | N/A | N/A | ||
| LOGC | LOGICBIO THERAPEUTICS INC | $19.12M | $7.77M | -$33.67M | -$36.41M | -$1.12 | 168.31% | N/A | N/A | N/A | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | $10.30B | $1.30B | $45.80M | $12.20M | $0.13 | 25.67% | 189.88% | -96.68% | N/A | ||
| OPNT | OPIANT PHARMACEUTICALS INC | $63.69M | $45.87M | -$3.68M | -$6.33M | -$1.11 | 44.56% | N/A | N/A | N/A | ||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.36B | $138.95M | $3.27M | $818.00k | $0.21 | 9,065.63% | 157.81% | N/A | N/A | ||
| NVO | NOVO NORDISK A S | $241.63B | $21.48B | $10.39B | $6.90B | $3.03 | 6.26% | 4.68% | 1.53% | 5.59% | ||
| HSTO | HISTOGEN INC | $5.64M | $4.36M | -$11.24M | -$11.35M | -$5.40 | 188.10% | -10.99% | N/A | N/A | 2022-08-11 | |
| RPRX | ROYALTY PHARMA PLC | $26.52B | $2.26B | $651.43M | $466.10M | $1.06 | 0.94% | N/A | -57.43% | N/A | ||
| LUMO | LUMOS PHARMA INC | $67.79M | $341.00k | -$30.15M | -$29.52M | -$3.49 | 131.97% | -59.88% | N/A | N/A | ||
| IMGN | IMMUNOGEN INC | $1.16B | $89.44M | -$158.82M | -$160.68M | -$0.69 | -34.54% | 0.09% | N/A | N/A | ||
| SELB | SELECTA BIOSCIENCES INC | $390.95M | $127.64M | $53.13M | $31.72M | $0.25 | 169.79% | 98.51% | N/A | N/A | ||
| VIR | VIR BIOTECHNOLOGY INC | $3.82B | $2.33B | $1.65B | $1.22B | $9.30 | 3,102.56% | N/A | N/A | N/A | ||
| ABCM | ABCAM PLC | $3.36B | $409.61M | $2.60M | $5.71M | $0.03 | 14.00% | N/A | N/A | N/A | ||
| LPTX | LEAP THERAPEUTICS INC | $96.27M | $1.13M | -$41.87M | -$41.83M | -$0.43 | -25.00% | N/A | N/A | N/A | 2022-08-11 | |
| MRUS | MERUS NV | $1.22B | $52.72M | -$52.56M | -$53.88M | -$1.29 | 37.59% | 35.00% | N/A | N/A | ||
| RPTX | REPARE THERAPEUTICS INC | $500.32M | $8.24M | -$129.10M | -$132.03M | -$3.28 | 1,321.03% | N/A | N/A | N/A | 2022-08-10 | |
| SEER | SEER INC | $641.28M | $9.87M | -$73.86M | -$78.39M | -$1.27 | 1,723.84% | N/A | N/A | N/A | ||
| ZLAB | ZAI LAB LTD | $4.43B | $170.93M | -$540.09M | -$553.96M | -$5.91 | 180.94% | N/A | N/A | N/A | ||
| STTK | SHATTUCK LABS INC | $155.11M | $27.75M | -$56.00M | -$57.69M | -$1.36 | 200.68% | N/A | N/A | N/A | ||
| CSBR | CHAMPIONS ONCOLOGY INC | $125.35M | $49.11M | $2.21M | $548.00k | $0.04 | 19.66% | 26.09% | 33.33% | N/A | 2022-09-12 | |
| FBIO | FORTRESS BIOTECH INC | $119.23M | $81.13M | -$51.22M | -$71.64M | -$2.26 | 83.27% | 6.04% | N/A | N/A | 2022-08-15 | |
| ADAG | ADAGENE INC | $62.89M | $10.18M | -$69.99M | -$73.21M | -$1.83 | 1,351.71% | N/A | N/A | N/A | ||
| AVEO | AVEO PHARMACEUTICALS INC | $265.15M | $79.04M | -$31.41M | -$36.14M | -$1.03 | 466.13% | 81.60% | N/A | N/A | ||
| ITCI | INTRA-CELLULAR THERAPIES INC | $5.31B | $102.92M | -$302.92M | -$303.50M | -$3.64 | 173.67% | 199.65% | N/A | N/A | ||
| ALBO | ALBIREO PHARMA INC | $488.23M | $45.45M | -$19.53M | -$32.73M | -$1.70 | 420.86% | 32.23% | N/A | N/A | 2022-08-15 | |
| BYSI | BEYONDSPRING INC | $57.22M | $1.35M | -$60.46M | -$64.18M | -$1.64 | 650.56% | N/A | N/A | N/A | ||
| ADMA | ADMA BIOLOGICS INC | $398.59M | $94.00M | -$59.17M | -$78.28M | -$0.48 | 95.55% | 53.12% | N/A | N/A | 2022-08-10 | |
| NBRV | NABRIVA THERAPEUTICS PLC | $122.44M | $35.33M | -$45.28M | -$46.61M | -$0.08 | 143.30% | 42.53% | N/A | N/A | ||
| NTRB | NUTRIBAND INC | $37.88M | $1.47M | -$6.13M | -$6.75M | -$0.98 | 16.60% | N/A | N/A | N/A | 2022-09-01 | |
| EYEN | EYENOVIA INC | $55.72M | $12.00M | -$13.97M | -$14.77M | -$0.52 | 200.00% | N/A | N/A | N/A | 2022-08-10 | |
| SYBX | SYNLOGIC INC | $69.97M | $2.00M | -$56.46M | -$61.29M | -$0.97 | 348.99% | 43.10% | N/A | N/A | 2022-08-11 | |
| LMNL | LIMINAL BIOSCIENCES INC | $15.52M | $338.28k | $24.83M | $17.04M | $0.59 | -41.79% | N/A | N/A | N/A | 2022-08-15 | |
| IVA | INVENTIVA SA | $204.37M | $9.45M | -$53.25M | -$55.15M | -$1.41 | 50.51% | N/A | N/A | N/A | ||
| QURE | UNIQURE NV | $888.79M | $61.97M | -$98.29M | -$114.06M | -$2.46 | -87.61% | 20.28% | N/A | N/A | ||
| FNCH | FINCH THERAPEUTICS GROUP INC | $117.47M | $15.33M | -$65.49M | -$68.75M | -$1.46 | 61.74% | N/A | N/A | N/A | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $900.35M | $38.51M | -$40.78M | -$53.09M | -$1.65 | 250.13% | N/A | N/A | N/A | ||
| ORGS | ORGENESIS INC | $41.20M | $33.33M | $17.09M | $13.83M | $0.89 | 119.78% | 37.71% | -73.35% | N/A | ||
| LEXX | LEXARIA BIOSCIENCE CORP | $16.60M | $175.27k | -$7.01M | -$6.98M | -$1.25 | -76.81% | 24.06% | N/A | N/A | ||
| XENE | XENON PHARMACEUTICALS INC | $2.09B | $22.85M | -$82.03M | -$81.12M | -$1.70 | -22.42% | 79.73% | N/A | N/A | ||
| DBVT | DBV TECHNOLOGIES SA | $519.02M | $8.33M | -$76.34M | -$77.45M | -$0.67 | 89.36% | N/A | N/A | N/A | ||
| EDIT | EDITAS MEDICINE INC | $1.24B | $31.80M | -$181.71M | -$184.49M | -$2.70 | -60.81% | 41.33% | N/A | N/A | ||
| ENTX | ENTERA BIO LTD | $51.27M | $482.00k | -$6.61M | -$6.48M | -$0.98 | 0.42% | N/A | N/A | N/A | 2022-08-15 | |
| GANX | GAIN THERAPEUTICS INC | $47.41M | $210.66k | -$16.19M | -$16.24M | -$1.36 | 91.03% | N/A | N/A | N/A | ||
| BGNE | BEIGENE LTD | $20.54B | $1.07B | -$1.96B | -$2.01B | -$1.58 | 12.84% | N/A | N/A | N/A | ||
| VCNX | VACCINEX INC | $45.22M | $50.00k | -$19.77M | -$20.40M | -$0.65 | -96.61% | N/A | N/A | N/A | 2022-08-15 | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $382.07M | $13.16M | -$84.04M | -$88.52M | -$2.44 | 129.20% | N/A | N/A | N/A | ||
| PRQR | PROQR THERAPEUTICS NV | $59.97M | $4.14M | -$59.42M | -$63.87M | -$0.91 | 174.11% | 25.36% | N/A | N/A | ||
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | $6.48B | $920.28M | $380.04M | $247.82M | $1.94 | 66.66% | N/A | -75.81% | N/A | ||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $98.56M | $1.21M | -$13.10M | -$13.75M | -$1.34 | -93.97% | N/A | N/A | N/A | 2022-08-17 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $17.75B | $1.91B | $177.12M | $54.07M | $0.29 | -0.26% | 9.74% | -93.72% | N/A | ||
| INMB | INMUNE BIO INC | $166.90M | $356.00k | -$32.87M | -$32.87M | -$1.87 | 2,273.33% | N/A | N/A | N/A | ||
| BLCM | BELLICUM PHARMACEUTICALS INC | $11.54M | $6.20M | -$5.94M | -$6.47M | -$0.02 | 1,140.00% | 71.00% | N/A | N/A | 2022-08-10 | |
| CGEN | COMPUGEN LTD | $124.74M | $6.00M | -$33.20M | -$33.66M | -$0.40 | 200.00% | 117.60% | N/A | N/A | ||
| HCM | HUTCHMED (CHINA) LTD | $2.36B | $400.81M | -$248.68M | -$255.11M | -$1.50 | 43.88% | 10.97% | N/A | N/A | ||
| RGNX | REGENXBIO INC | $1.47B | $484.30M | $140.95M | $90.72M | $2.20 | 200.29% | 122.72% | N/A | N/A | ||
| RCUS | ARCUS BIOSCIENCES INC | $1.82B | $408.72M | $80.87M | $66.77M | $1.04 | 339.78% | N/A | N/A | N/A | ||
| ITOS | ITEOS THERAPEUTICS INC | $929.74M | $497.30M | $390.19M | $297.64M | $8.45 | N/A | N/A | N/A | N/A | 2022-08-10 | |
| JANX | JANUX THERAPEUTICS INC | $518.70M | $4.85M | -$43.61M | -$43.80M | -$1.49 | 1,175.26% | N/A | N/A | N/A | ||
| SPRC | SCISPARC LTD | $3.86M | $0.00 | -$1.74M | -$1.75M | $0.86 | N/A | N/A | 2,751.61% | N/A | ||
| MESO | MESOBLAST LTD | $401.65M | $9.98M | -$80.41M | -$91.95M | -$0.71 | 62.01% | -19.05% | N/A | N/A | ||
| ICCC | IMMUCELL CORP | $69.07M | $21.14M | $3.57M | $1.10M | $0.15 | 45.37% | 15.91% | N/A | 2.90% | 2022-08-11 | |
| ROIV | ROIVANT SCIENCES LTD | $2.79B | $46.06M | -$555.63M | -$556.18M | $0.02 | N/A | N/A | N/A | N/A | ||
| XNCR | XENCOR INC | $1.74B | $289.37M | $30.99M | $22.49M | $0.40 | 61.99% | 41.09% | 0.00% | N/A | ||
| FSTX | F-STAR THERAPEUTICS INC | $140.78M | $20.80M | -$32.71M | -$33.79M | -$1.54 | 62.28% | 210.56% | N/A | N/A | 2022-08-10 | |
| CTXR | CITIUS PHARMACEUTICALS INC | $138.82M | $0.00 | -$27.40M | -$29.02M | -$0.19 | N/A | N/A | N/A | N/A | 2022-08-10 | |
| ONTX | ONCONOVA THERAPEUTICS INC | $26.96M | $226.00k | -$15.56M | -$15.57M | -$0.85 | -3.83% | -44.47% | N/A | N/A | 2022-08-11 | |
| HUMA | HUMACYTE INC | $354.34M | $1.34M | -$12.51M | -$26.01M | $1.36 | -3.59% | N/A | N/A | N/A | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $442.56M | $71.81M | -$235.95M | -$247.65M | -$2.55 | 867.54% | N/A | N/A | N/A | ||
| DYAI | DYADIC INTERNATIONAL INC | $74.90M | $2.59M | -$12.27M | -$12.27M | -$0.44 | 48.35% | N/A | N/A | N/A | 2022-08-10 |
Biotech Stocks FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.